207 - Infectious Complications of Immunomodulatory Biologic Agents: Risk Assessment, Diagnosis, and Management

10/5/2019

8:00 AM - 9:00 AM

Room: Walter E. Washington Convention Center, 209 ABC

MOC Credit: Maximum of 1 hours of MOC Credit
CME Credit: Maximum of 1 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-400-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe key elements for assessing risk of infection prior to initiation of immunomodulatory biologic drugs
review major infections associated with immunomodulatory drugs
discuss best practices for management of infections in patients who are taking immunomodulatory biologic drugs

Presentations:

8:00 AM - 9:00 AM
1903 - Infectious Complications of Immunomodulatory Biologic Agents
Cassandra Calabrese, DO – Cleveland Clinic Foundation
8:00 AM - 9:00 AM
1902 - Infectious Complications of Immunomodulatory Biologic Agents
Kevin L. Winthrop, MD, MPH – Oregon Health & Science University

Speaker(s)

Cassandra Calabrese, DO

Associate Staff
Cleveland Clinic Foundation
Cleveland, OH

Disclosure: Sanofi-Regeneron: Speaker's Bureau
KW

Kevin Winthrop, MD, MPH

Associate Professor
Oregon Health & Science University
Portland, OR